Drug and Chemical Toxicology is a well-respected journal in the fields of toxicology, pharmacology, and public health, published by Taylor & Francis Ltd. Since its inception in 1978, this journal has diligently explored the effects and mechanisms of chemical exposures on health and the environment, fulfilling a crucial role in advancing scientific understanding and safeguarding public health. The journal is indexed across prestigious databases and features an impressive array of articles categorized within the Q2 and Q3 quartiles across various categories in 2023, reflecting its significance in Chemical Health and Safety as well as Environmental and Occupational Health disciplines. With an extensive reach and a focus on interdisciplinary research, Drug and Chemical Toxicology offers a rich repository of original research, reviews, and methodological advancements, catering to a diverse audience of researchers, professionals, and students dedicated to the betterment of safety and health standards. Although not an open-access publication, its articles are widely accessible to the academic community, ensuring that critical innovations and insights are shared for the greater good.

CARDIOVASCULAR RESEARCH, published by Oxford University Press, is a premier academic journal dedicated to the evolving field of cardiology and cardiovascular medicine. With a remarkable impact factor reflecting its significant contribution to the scientific community, this journal maintains a Q1 ranking in both Cardiology and Physiology categories, demonstrating its commitment to publishing high-quality research that influences clinical practices and healthcare outcomes. Established in 1967, the journal has consistently provided a platform for innovative studies and reviews, aiming to advance our understanding of cardiovascular physiology and pathology. Researchers, professionals, and students will find published articles crucial for their work, as the journal covers a broad spectrum of topics including molecular biology, genetics, and clinical studies. While currently not offering open access options, CARDIOVASCULAR RESEARCH remains accessible through institutional and individual subscriptions, ensuring that the latest findings are available to those in the cardiovascular science community.

TOXICOLOGY MECHANISMS AND METHODS is a distinguished peer-reviewed journal dedicated to the advancement of toxicological research, published by Taylor & Francis Ltd. With its ISSN 1537-6516 and E-ISSN 1537-6524, this esteemed journal features critical studies and innovative methodologies in the field of toxicology, aligning with its mission to enhance understanding of biological mechanisms and risk assessment. The journal holds a commendable Q2 ranking in both the Health, Toxicology and Mutagenesis, and Toxicology categories, as well as strong positions in Scopus rankings, reflecting its influence with a 71st percentile rank in Toxicology and a 69th percentile rank in Environmental Health. Researchers, professionals, and students in the toxicology domain will find this journal to be an invaluable resource, offering open access options that foster widespread dissemination of its findings. Since its inception, encompassing converged years from 1991 to 1995 and from 2002 to 2024, the journal remains at the forefront of critical discourse and innovative research methods, making it a vital platform for advancing toxicological science globally.

The Journal of Toxicological Sciences, published by the Japanese Society of Toxicological Sciences, is a prominent academic journal dedicated to the comprehensive study of toxicology and its related fields. Since its inception in 1976, the journal has provided a vital platform for researchers and professionals to disseminate innovative findings and insights in toxicology, with a focus on both experimental and clinical studies. Positioned in the Q3 quartile across various relevant categories, including Medicine (miscellaneous) and Toxicology as of 2023, the journal plays an essential role in advancing our understanding of toxic substances and their effects on biological systems. Although currently not open access, the journal maintains high academic standards and is indexed in Scopus, ranking #96 in Toxicology. Offering unique perspectives from Japan, it encourages global collaboration and discourse among toxicologists, making it an invaluable resource for students, researchers, and industry professionals alike.

TOXICOLOGY AND INDUSTRIAL HEALTH, published by SAGE PUBLICATIONS INC, is a premier journal in the field of toxicology, public health, and environmental health, with a significant history dating back to 1985. With its ISSN 0748-2337 and E-ISSN 1477-0393, the journal provides a platform for disseminating groundbreaking research and comprehensive reviews that address the complexities of toxic substances in industrial and occupational settings. Despite its Q3 ranking among peers in health, toxicology, and public health, this journal is becoming increasingly influential, reflected in its growing citation metrics. Researchers and professionals benefit from its commitment to fostering knowledge in both theoretical and practical contexts, making it an essential resource for those dedicated to advancing understanding in this vital field. The journal's main objectives include promoting research addressing the implications of toxicology on health and safety standards across industries, ensuring accessibility to current studies for a global audience. Overall, TOXICOLOGY AND INDUSTRIAL HEALTH plays a critical role in bridging the gap between research and real-world applications, proving invaluable to students, professionals, and researchers alike in their pursuit of enhancing public health and environmental safety.

Genes and Environment is a premier interdisciplinary journal published by BMC that explores the dynamic interplay between genetic factors and environmental influences shaping health and behavior. Since its inception, the journal has gained recognition for its commitment to providing open access (since 2015) to groundbreaking research, fostering an inclusive platform for scholars worldwide. With an ISSN of 1880-7046 and an E-ISSN of 1880-7062, Genes and Environment consistently ranks in Q2 in Environmental Science, Q3 in Genetics, and Q2 in Social Psychology according to the 2023 category quartiles, highlighting its significant contributions to these fields. The journal is headquartered in the United Kingdom and has a diverse portfolio of research spanning from 2006 to 2024. It is recognized in Scopus with commendable rankings across various disciplines. By fostering dialogue among researchers, professionals, and students, Genes and Environment serves as a vital resource for understanding complex biological interactions with environmental factors, ultimately aiming to advance knowledge and inform public policy.

Frontiers in Toxicology, published by Frontiers Media SA, is a prominent open-access journal dedicated to advancing the understanding of toxicological science. Established in 2019, it serves as a vital forum for innovative research, offering insights into the pharmacological impacts and toxicological profiles of various substances. With its international reach based in Switzerland, this journal has quickly ascended in the academic community, achieving a notable Q1 ranking in Pharmacology, Toxicology and Pharmaceutics (Miscellaneous) and a Q2 ranking in Toxicology as of 2023. The journal is indexed in Scopus, where it ranks #8 out of 43 in its primary category, underscoring its influence and relevance in the field. The scope encompasses cutting-edge studies on the mechanisms of toxicity, including both human and environmental impacts, making it an essential resource for researchers, professionals, and students alike. By promoting open access to high-quality research, Frontiers in Toxicology plays a crucial role in enhancing knowledge sharing and fostering collaboration across disciplines.

Cardio-Oncology, published by BMC since 2015, serves as a premier open-access journal dedicated to the intersection of cardiology and oncology, ensuring that vital research reaches a global audience without barriers. With an impactful presence in the United Kingdom and an impressive Q1 ranking in Cardiology and Cardiovascular Medicine, alongside a Q2 ranking in Oncology as of 2023, the journal captures the growing importance of managing cardiovascular health in cancer patients. Aimed at researchers, healthcare professionals, and students, Cardio-Oncology publishes high-quality research, reviews, and clinical studies that advance understanding in this critical field, fostering an interdisciplinary dialogue essential for improving patient outcomes. Accessible and relevant, the journal reflects the concerted effort to bridge gaps in knowledge and address the complexities faced by healthcare providers managing the dual challenges of cancer and cardiovascular disease.

KARDIOLOGIYA is a renowned academic journal in the field of cardiology, published by the Russian Heart Failure Society. Since its inception in 1961, this journal has been dedicated to disseminating cutting-edge research in cardiovascular medicine, contributing to the global understanding of heart-related diseases and their management. With a significant publication history that spans over six decades, KARDIOLOGIYA provides a platform for both established researchers and emerging scholars to publish their findings. Despite its current Q4 category ranking in the 2023 Cardiology and Cardiovascular Medicine category, the journal plays a crucial role in promoting regional insights and advancements in cardiology, while striving towards higher visibility and impact within the academic community. While not an open-access journal, the journal is accessible to institutions and professionals in the Russian Federation and beyond, fostering collaboration and knowledge sharing among healthcare professionals. With a Scopus rank of #259 among 387 journals, it is well-positioned to enhance discourse in the field and support the development of innovative approaches to cardiovascular care.

TOXICOLOGY AND APPLIED PHARMACOLOGY, published by Academic Press, Inc. Elsevier Science, stands as a leading journal in the domains of toxicology and pharmacology, with its establishment dating back to 1959. With an impact factor reflecting its academic rigor and relevance, this journal is classified in the Q2 quartile for both pharmacology and toxicology categories, underscoring its significance in the scientific community. It ranks #34 out of 133 in Toxicology and #95 out of 313 in Pharmacology according to Scopus, placing it within the 74th and 69th percentiles, respectively. The journal aims to disseminate quality research that drives advancements in understanding the interactions of drugs and toxic substances within biological systems. Researchers and professionals are invited to contribute and engage with a broad spectrum of articles that cover mechanistic studies, risk assessment, and innovative therapeutic strategies. Although the journal does not offer open access, it continues to be a crucial resource for those who seek to navigate the complex interface of drugs and their toxicological implications.